Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
PDGFRB | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 2.32E5 | Evidence | O | ||||
PDGFRB | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 1.37E5 | Evidence | |||||
PDGFRB | CRKL | CRKL: Crk-like protein | 1.22E5 | Evidence | |||||
PDGFRB | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 1.21E5 | Evidence | |||||
PDGFRB | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 9.66E4 | Evidence | |||||
PDGFRB | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 8.52E4 | Evidence | |||||
PDGFRB | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 7.21E4 | Evidence | O | ||||
PDGFRB | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 6.45E4 | Evidence | |||||
PDGFRB | VAV1 | VAV1, VAV: Proto-oncogene vav | 6.45E4 | Evidence | |||||
PDGFRB | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 6.35E4 | Evidence | |||||
PDGFRB | FRK | FRK, PTK5, RAK: Tyrosine-protein kinase FRK | 6.35E4 | Evidence | |||||
PDGFRB | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 5.72E4 | Evidence | |||||
PDGFRB | HCK | N/A | 5.72E4 | Evidence | |||||
PDGFRB | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 5.32E4 | Evidence | |||||
PDGFRB | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 4.20E4 | Evidence | |||||
PDGFRB | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 3.47E4 | Evidence | O | ||||
PDGFRB | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 3.38E4 | Evidence | |||||
PDGFRB | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 3.15E4 | Evidence | |||||
PDGFRB | GRAP | GRAP: GRB2-related adapter protein | 3.04E4 | Evidence | |||||
PDGFRB | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 2.57E4 | Evidence | |||||
PDGFRB | KIT | KIT: Mast/stem cell growth factor receptor precursor | 2.57E4 | Evidence | |||||
PDGFRB | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 2.27E4 | Evidence | |||||
PDGFRB | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 1.92E4 | Evidence | |||||
PDGFRB | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 1.88E4 | Evidence | |||||
PDGFRB | JUP | JUP, CTNNG, DP3: Junction plakoglobin | 8.68E3 | Evidence | |||||
PDGFRB | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 3.62E3 | Evidence | |||||
PDGFRB | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 1.50E3 | Evidence | |||||
PDGFRB | NCK2 | NCK2: Cytoplasmic protein NCK2 | 519.0 | Evidence | O | ||||
PDGFRB | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 258.0 | Evidence | |||||
PDGFRB | FIGF | FIGF, VEGFD: Vascular endothelial growth factor D precursor | 245.0 | Evidence | |||||
PDGFRB | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 243.0 | Evidence | |||||
PDGFRB | PLCG2 | PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 | 230.0 | Evidence | |||||
PDGFRB | LNK | SH2B3, LNK: SH2B adapter protein 3 | 224.0 | Evidence | |||||
PDGFRB | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 224.0 | Evidence | |||||
PDGFRB | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 224.0 | Evidence | |||||
PDGFRB | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 224.0 | Evidence | |||||
PDGFRB | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 224.0 | Evidence | |||||
PDGFRB | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 209.0 | Evidence | |||||
PDGFRB | BMX | N/A | 206.0 | Evidence | |||||
PDGFRB | STAT3 | 200.0 | Evidence | ||||||
PDGFRB | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 167.0 | Evidence | |||||
PDGFRB | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 167.0 | Evidence | |||||
PDGFRB | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 149.0 | Evidence | |||||
PDGFRB | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 149.0 | Evidence | |||||
PDGFRB | SYK | SYK: Tyrosine-protein kinase SYK | 149.0 | Evidence | |||||
PDGFRB | JAK1 | 147.0 | Evidence | ||||||
PDGFRB | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 147.0 | Evidence | |||||
PDGFRB | GRB10 | N/A | 141.0 | Evidence | |||||
PDGFRB | CRK | CRK: Proto-oncogene C-crk | 141.0 | Evidence | |||||
PDGFRB | APS | SH2B2, APS: SH2B adapter protein 2 | 134.0 | Evidence | |||||
PDGFRB | LYN | LYN: Tyrosine-protein kinase Lyn | 134.0 | Evidence | |||||
PDGFRB | CSK | CSK: Tyrosine-protein kinase CSK | 134.0 | Evidence | |||||
PDGFRB | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 132.0 | Evidence | |||||
PDGFRB | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 132.0 | Evidence | |||||
PDGFRB | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 132.0 | Evidence | |||||
PDGFRB | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 119.0 | Evidence | |||||
PDGFRB | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 112.0 | Evidence | |||||
PDGFRB | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 90.70 | Evidence | |||||
PDGFRB | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 89.30 | Evidence | |||||
PDGFRB | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 82.40 | Evidence | |||||
PDGFRB | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 81.20 | Evidence | |||||
PDGFRB | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 80.50 | Evidence | |||||
PDGFRB | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 73.20 | Evidence | |||||
PDGFRB | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 72.70 | Evidence | |||||
PDGFRB | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 64.10 | Evidence | |||||
PDGFRB | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 59.60 | Evidence | |||||
PDGFRB | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 57.50 | Evidence | |||||
PDGFRB | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 49.70 | Evidence | |||||
PDGFRB | CNN3 | CNN3: Calponin-3 | 46.30 | Evidence | |||||
PDGFRB | GHR | GHR: Growth hormone receptor precursor | 43.60 | Evidence | |||||
PDGFRB | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 39.10 | Evidence | |||||
PDGFRB | ITGAV | ITGAV, MSK8, VNRA: Integrin alpha-V precursor | 39.10 | Evidence | |||||
PDGFRB | GNA11 | GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 | 38.00 | Evidence | |||||
PDGFRB | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 37.90 | Evidence | |||||
PDGFRB | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 37.80 | Evidence | |||||
PDGFRB | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 37.80 | Evidence | |||||
PDGFRB | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 37.80 | Evidence | |||||
PDGFRB | FGFR1 | FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor | 37.80 | Evidence | |||||
PDGFRB | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 37.80 | Evidence | |||||
PDGFRB | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 37.80 | Evidence | |||||
PDGFRB | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 37.80 | Evidence | |||||
PDGFRB | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 37.80 | Evidence | |||||
PDGFRB | KIR3DL1 | N/A | 37.80 | Evidence | |||||
PDGFRB | TRPV4 | TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb | 37.80 | Evidence | |||||
PDGFRB | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 37.80 | Evidence | |||||
PDGFRB | GRB14 | GRB14: Growth factor receptor-bound protein 14 | 37.10 | Evidence | O | ||||
PDGFRB | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 37.10 | Evidence | |||||
PDGFRB | MERTK | MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor | 34.80 | Evidence | |||||
PDGFRB | DAB2 | DAB2, DOC2: Disabled homolog 2 | 33.90 | Evidence | |||||
PDGFRB | CNTN1 | CNTN1: Contactin-1 precursor | 33.90 | Evidence | |||||
PDGFRB | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 33.90 | Evidence | |||||
PDGFRB | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 33.90 | Evidence | |||||
PDGFRB | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 33.90 | Evidence | |||||
PDGFRB | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 33.90 | Evidence | |||||
PDGFRB | EPHA8 | EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor | 33.90 | Evidence | |||||
PDGFRB | ATRN | N/A | 33.90 | Evidence | |||||
PDGFRB | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 33.90 | Evidence | |||||
PDGFRB | SHB | SHB: SH2 domain-containing adapter protein B | 33.20 | Evidence | O | ||||
PDGFRB | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 32.70 | Evidence | O | ||||
PDGFRB | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 31.20 | Evidence | |||||
PDGFRB | INSR | INSR: Insulin receptor precursor | 31.20 | Evidence | |||||
PDGFRB | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 31.20 | Evidence | |||||
PDGFRB | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 31.20 | Evidence | |||||
PDGFRB | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 29.40 | Evidence | |||||
PDGFRB | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 29.00 | Evidence | |||||
PDGFRB | CTTN | CTTN, EMS1: Src substrate cortactin | 28.70 | Evidence | |||||
PDGFRB | IRS1 | IRS1: Insulin receptor substrate 1 | 28.70 | Evidence | |||||
PDGFRB | PRLR | PRLR: Prolactin receptor precursor | 28.20 | Evidence | |||||
PDGFRB | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 28.20 | Evidence | |||||
PDGFRB | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 28.20 | Evidence | |||||
PDGFRB | EGF | EGF: Pro-epidermal growth factor precursor | 28.20 | Evidence | |||||
PDGFRB | MET | MET: Hepatocyte growth factor receptor precursor | 28.20 | Evidence | |||||
PDGFRB | THY1 | THY1: Thy-1 membrane glycoprotein precursor | 28.20 | Evidence | |||||
PDGFRB | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 28.20 | Evidence | |||||
PDGFRB | SCARB2 | SCARB2, CD36L2, LIMPII: Lysosome membrane protein 2 | 26.00 | Evidence | |||||
PDGFRB | SHC2 | N/A | 25.70 | Evidence | |||||
PDGFRB | FABP4 | FABP4: Fatty acid-binding protein, adipocyte | 25.50 | Evidence | |||||
PDGFRB | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 25.3 | Evidence | |||||
PDGFRB | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 25.3 | Evidence | |||||
PDGFRB | ITGB3 | ITGB3, GP3A: Integrin beta-3 precursor | 25.3 | Evidence | |||||
PDGFRB | CD3D | CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor | 25.20 | Evidence | |||||
PDGFRB | ICAM3 | ICAM3: Intercellular adhesion molecule 3 precursor | 25.20 | Evidence | |||||
PDGFRB | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 25.20 | Evidence | |||||
PDGFRB | CD58 | CD58, LFA3: Lymphocyte function-associated antigen 3 precursor | 25.20 | Evidence | |||||
PDGFRB | PSCD1 | PSCD1, D17S811E: Cytohesin-1 | 24.90 | Evidence | |||||
PDGFRB | ABI1 | ABI1, SSH3BP1: Abl interactor 1 | 24.90 | Evidence | |||||
PDGFRB | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 24.90 | Evidence | |||||
PDGFRB | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 24.90 | Evidence | |||||
PDGFRB | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 24.80 | Evidence | |||||
PDGFRB | NCAM1 | NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor | 24.80 | Evidence | |||||
PDGFRB | ITGB4 | N/A | 24.80 | Evidence | |||||
PDGFRB | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 24.80 | Evidence | |||||
PDGFRB | EPOR | EPOR: Erythropoietin receptor precursor | 24.80 | Evidence | |||||
PDGFRB | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 24.80 | Evidence | |||||
PDGFRB | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 24.80 | Evidence | |||||
PDGFRB | TNNC1 | TNNC1, TNNC: Troponin C, slow skeletal and cardiac muscles | 22.90 | Evidence | |||||
PDGFRB | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 22.90 | Evidence | |||||
PDGFRB | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 22.90 | Evidence | |||||
PDGFRB | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 22.40 | Evidence | |||||
PDGFRB | CD22 | CD22, SIGLEC2: B-cell receptor CD22 precursor | 22.40 | Evidence | |||||
PDGFRB | SLAMF1 | SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor | 22.40 | Evidence | |||||
PDGFRB | CD4 | CD4: T-cell surface glycoprotein CD4 precursor | 22.40 | Evidence | |||||
PDGFRB | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 22.40 | Evidence | |||||
PDGFRB | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 22.40 | Evidence | |||||
PDGFRB | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 22.40 | Evidence | |||||
PDGFRB | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 22.40 | Evidence | |||||
PDGFRB | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 22.30 | Evidence | |||||
PDGFRB | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 22.30 | Evidence | |||||
PDGFRB | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 22.30 | Evidence | |||||
PDGFRB | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 22.30 | Evidence | |||||
PDGFRB | ASGR1 | ASGR1: Asialoglycoprotein receptor 1 | 22.20 | Evidence | |||||
PDGFRB | ROBO1 | ROBO1, DUTT1: Roundabout homolog 1 precursor | 22.20 | Evidence | |||||
PDGFRB | DCC | DCC: Netrin receptor DCC precursor | 22.20 | Evidence | |||||
PDGFRB | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 22.20 | Evidence | |||||
PDGFRB | EPHA2 | EPHA2, ECK: Ephrin type-A receptor 2 precursor | 22.20 | Evidence | |||||
PDGFRB | SNTA1 | SNTA1, SNT1: Alpha-1-syntrophin | 20.50 | Evidence | |||||
PDGFRB | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 20.50 | Evidence | |||||
PDGFRB | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 20.00 | Evidence | |||||
PDGFRB | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 20.00 | Evidence | |||||
PDGFRB | CAV1 | CAV1, CAV: Caveolin-1 | 19.50 | Evidence | |||||
PDGFRB | PLAUR | PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor | 19.10 | Evidence | |||||
PDGFRB | LAT | LAT: Linker for activation of T-cells family member 1 | 19.10 | Evidence | |||||
PDGFRB | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 19.10 | Evidence | |||||
PDGFRB | FGFR4 | FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor | 18.90 | Evidence | |||||
PDGFRB | GNAI1 | GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit | 18.60 | Evidence | |||||
PDGFRB | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 18.60 | Evidence | |||||
PDGFRB | LIF | LIF, HILDA: Leukemia inhibitory factor precursor | 18.60 | Evidence | |||||
PDGFRB | S100A11 | MLN70, S100A11, S100C: Protein S100-A11 | 18.60 | Evidence | |||||
PDGFRB | CXCL1 | CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor | 18.60 | Evidence | |||||
PDGFRB | PDGFA | PDGFA, PDGF1: Platelet-derived growth factor A chain precursor | 18.60 | Evidence | |||||
PDGFRB | CXCL5 | CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor | 18.60 | Evidence | |||||
PDGFRB | CSH2 | GH1: Somatotropin precursor | 18.60 | Evidence | |||||
PDGFRB | TNFRSF1A | TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre | 17.50 | Evidence | |||||
PDGFRB | TIMP2 | TIMP2: Metalloproteinase inhibitor 2 precursor | 17.20 | Evidence | |||||
PDGFRB | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 17.10 | Evidence | |||||
PDGFRB | ATP2A2 | ATP2A2, ATP2B: Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 17.10 | Evidence | |||||
PDGFRB | GNAI3 | GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha | 16.7 | Evidence | |||||
PDGFRB | MYL4 | MYL4, MLC1, PRO1957: Myosin light polypeptide 4 | 16.60 | Evidence | |||||
PDGFRB | SH3BP5 | N/A | 16.60 | Evidence | |||||
PDGFRB | PLD2 | PLD2: Phospholipase D2 | 16.60 | Evidence | |||||
PDGFRB | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 16.60 | Evidence | |||||
PDGFRB | IRS2 | IRS2: Insulin receptor substrate 2 | 16.40 | Evidence | |||||
PDGFRB | IL1B | IL1B, IL1F2: Interleukin-1 beta precursor | 16.40 | Evidence | |||||
PDGFRB | GAB1 | GAB1: GRB2-associated-binding protein 1 | 16.40 | Evidence | |||||
PDGFRB | MCF2 | MCF2, DBL: Proto-oncogene DBL | 16.40 | Evidence | |||||
PDGFRB | CETN1 | CETN1, CEN1, CETN: Centrin-1 | 15.70 | Evidence | |||||
PDGFRB | LILRB1 | N/A | 15.30 | Evidence | |||||
PDGFRB | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 15.10 | Evidence | |||||
PDGFRB | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 14.90 | Evidence | |||||
PDGFRB | LCP1 | LCP1, PLS2: Plastin-2 | 14.90 | Evidence | |||||
PDGFRB | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 14.90 | Evidence | |||||
PDGFRB | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 14.90 | Evidence | |||||
PDGFRB | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 14.90 | Evidence | |||||
PDGFRB | CD2AP | CD2AP: CD2-associated protein | 14.90 | Evidence | |||||
PDGFRB | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 14.70 | Evidence | |||||
PDGFRB | MMP13 | MMP13: Collagenase 3 precursor | 14.70 | Evidence | |||||
PDGFRB | BMP7 | BMP7, OP1: Bone morphogenetic protein 7 precursor | 14.60 | Evidence | |||||
PDGFRB | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 14.60 | Evidence | |||||
PDGFRB | HPCAL1 | HPCAL1, BDR1: Hippocalcin-like protein 1 | 14.60 | Evidence | |||||
PDGFRB | STAM2 | STAM2: Signal transducing adapter molecule 2 | 14.60 | Evidence | |||||
PDGFRB | DAB1 | DAB1: Disabled homolog 1 | 14.60 | Evidence | |||||
PDGFRB | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 14.20 | Evidence | |||||
PDGFRB | NGFR | NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor | 14.20 | Evidence | |||||
PDGFRB | H2-ALPHA | TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain | 14.10 | Evidence | |||||
PDGFRB | HLA-DMA | DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP | 13.50 | Evidence | |||||
PDGFRB | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor | 13.50 | Evidence | |||||
PDGFRB | CNN1 | CNN1: Calponin-1 | 13.50 | Evidence | |||||
PDGFRB | LATS2 | LATS2, KPM: Serine/threonine-protein kinase LATS2 | 13.50 | Evidence | |||||
PDGFRB | ARHGEF7 | N/A | 13.50 | Evidence | |||||
PDGFRB | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 13.20 | Evidence | |||||
PDGFRB | DOK1 | DOK1: Docking protein 1 | 13.20 | Evidence | |||||
PDGFRB | CNKSR2 | CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 | 13.20 | Evidence | |||||
PDGFRB | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 13.20 | Evidence | |||||
PDGFRB | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 13.20 | Evidence | |||||
PDGFRB | TGFBR1 | TGFBR1: TGF-beta receptor type-1 precursor | 12.70 | Evidence | |||||
PDGFRB | CD36 | CD36, GP3B, GP4: Platelet glycoprotein 4 | 12.70 | Evidence | |||||
PDGFRB | CD5 | CD5, LEU1: T-cell surface glycoprotein CD5 precursor | 12.70 | Evidence | |||||
PDGFRB | CCR5 | CCR5: CCR5 receptor (Fragment) | 12.70 | Evidence | |||||
PDGFRB | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 12.70 | Evidence | |||||
PDGFRB | CD44 | N/A | 12.50 | Evidence | |||||
PDGFRB | SOCS7 | SOCS7, NAP4, SOCS6: Suppressor of cytokine signaling 7 | 12.40 | Evidence | |||||
PDGFRB | EPS15 | EPS15, AF1P: Epidermal growth factor receptor substrate 15 | 11.80 | Evidence | |||||
PDGFRB | IGHA2 | IGHA2: Ig alpha-2 chain C region | 11.70 | Evidence | |||||
PDGFRB | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-68 alpha chain precursor | 11.70 | Evidence | |||||
PDGFRB | EVL | EVL, RNB6: Ena/VASP-like protein | 11.70 | Evidence | |||||
PDGFRB | HLA-DQB1 | HLA-DQB1: HLA class II histocompatibility antigen, DQB1*0602 beta chain precurso | 11.70 | Evidence | |||||
PDGFRB | NULL | Ig lambda chain V-II region NEI | 11.70 | Evidence | |||||
PDGFRB | RAPH1 | N/A | 11.70 | Evidence | |||||
PDGFRB | MAP3K9 | MAP3K9, MLK1, PRKE1: Mitogen-activated protein kinase kinase kinase 9 | 11.70 | Evidence | |||||
PDGFRB | C6orf21 | LY6G6F, C6orf21, G6F, LY6G6D, NG32: Lymphocyte antigen 6 complex locus protein G | 11.70 | Evidence | |||||
PDGFRB | SNX2 | SNX2, TRG9: Sorting nexin-2 | 11.70 | Evidence | |||||
PDGFRB | LOC649805 | Ig heavy chain V-II region COR | 11.70 | Evidence | |||||
PDGFRB | CEBPA | CEBPA: CCAAT/enhancer-binding protein alpha | 11.70 | Evidence | |||||
PDGFRB | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 11.60 | Evidence | |||||
PDGFRB | MS4A1 | MS4A1, CD20: B-lymphocyte antigen CD20 | 11.30 | Evidence | |||||
PDGFRB | AKAP12 | AKAP12, AKAP250: A-kinase anchor protein 12 | 11.20 | Evidence | |||||
PDGFRB | ANXA2 | ANXA2, ANX2, ANX2L4, CAL1H, LPC2D: Annexin A2 | 11.00 | Evidence | |||||
PDGFRB | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 10.80 | Evidence | |||||
PDGFRB | IGFBP3 | IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor | 10.50 | Evidence | |||||
PDGFRB | PPP1R14A | PPP1R14A, CPI17, PPP1INL: Protein phosphatase 1 regulatory subunit 14A | 10.50 | Evidence | |||||
PDGFRB | FLT4 | VEGFR3 long form | 10.50 | Evidence | |||||
PDGFRB | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 10.50 | Evidence | |||||
PDGFRB | SOS1 | SOS1: Son of sevenless homolog 1 | 10.50 | Evidence | |||||
PDGFRB | MOS | MOS: Proto-oncogene serine/threonine-protein kinase mos | 10.30 | Evidence | |||||
PDGFRB | RYR2 | RYR2: Ryanodine receptor 2 | 10.30 | Evidence | |||||
PDGFRB | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 10.10 | Evidence | |||||
PDGFRB | ADRB2 | ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor | 10.10 | Evidence | |||||
PDGFRB | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 10.10 | Evidence | |||||
PDGFRB | NEK6 | NEK6: Serine/threonine-protein kinase Nek6 | 10.00 | Evidence | |||||
PDGFRB | CDC2 | CDC2: Cell division control protein 2 homolog | 10.00 | Evidence | |||||
PDGFRB | IQGAP2 | IQGAP2: Ras GTPase-activating-like protein IQGAP2 | 9.41 | Evidence | |||||
PDGFRB | TIAM1 | TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 | 9.33 | Evidence | |||||
PDGFRB | MYO3A | MYO3A: Myosin IIIA | 9.29 | Evidence | |||||
PDGFRB | KRT6E | KRT6C, KRT6E: Keratin, type II cytoskeletal 6C | 9.16 | Evidence | |||||
PDGFRB | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 9.04 | Evidence | |||||
PDGFRB | GAB2 | N/A | 8.96 | Evidence | |||||
PDGFRB | SASH1 | SASH1, KIAA0790, PEPE1: SAM and SH3 domain-containing protein 1 | 8.92 | Evidence | |||||
PDGFRB | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 8.90 | Evidence | |||||
PDGFRB | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 8.79 | Evidence | |||||
PDGFRB | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 8.78 | Evidence | |||||
PDGFRB | MICAL-L1 | MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 | 8.40 | Evidence | |||||
PDGFRB | SVIL | SVIL: Supervillin | 8.20 | Evidence | |||||
PDGFRB | TNN | TNN: Tenascin-N precursor | 7.87 | Evidence | |||||
PDGFRB | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 7.74 | Evidence | |||||
PDGFRB | MAL2 | MAL2: Protein MAL2 | 7.72 | Evidence | |||||
PDGFRB | SYTL4 | Endocrine transmitter regulatory protein | 7.72 | Evidence | |||||
PDGFRB | FADD | FADD, MORT1: Protein FADD | 7.61 | Evidence | |||||
PDGFRB | DYRK3 | N/A | 7.52 | Evidence | |||||
PDGFRB | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 7.52 | Evidence | |||||
PDGFRB | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 7.52 | Evidence | |||||
PDGFRB | HD | HD, IT15: Huntingtin | 7.51 | Evidence | |||||
PDGFRB | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 7.51 | Evidence | |||||
PDGFRB | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 7.51 | Evidence | |||||
PDGFRB | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 7.47 | Evidence | |||||
PDGFRB | K-ALPHA-1 | TUBA1B: Tubulin alpha-1B chain | 7.47 | Evidence | |||||
PDGFRB | WEE1 | WEE1: Wee1-like protein kinase | 7.40 | Evidence | |||||
PDGFRB | F13B | F13B: Coagulation factor XIII B chain precursor | 7.40 | Evidence | |||||
PDGFRB | PIP5K3 | PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase | 7.17 | Evidence | |||||
PDGFRB | NULL | Ig heavy chain V-III region WEA | 7.14 | Evidence | |||||
PDGFRB | FRS2 | FRS2: Fibroblast growth factor receptor substrate 2 | 6.93 | Evidence | |||||
PDGFRB | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 6.82 | Evidence | |||||
PDGFRB | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 6.73 | Evidence | |||||
PDGFRB | PITPNM1 | PITPNM1: Uncharacterized protein PITPNM1 | 6.73 | Evidence | |||||
PDGFRB | MLH1 | MLH1, COCA2: DNA mismatch repair protein Mlh1 | 6.73 | Evidence | |||||
PDGFRB | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 6.73 | Evidence | O | ||||
PDGFRB | SF3B1 | SF3B1, SAP155: Splicing factor 3B subunit 1 | 6.73 | Evidence | |||||
PDGFRB | WASPIP | N/A | 6.73 | Evidence | |||||
PDGFRB | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 6.73 | Evidence | |||||
PDGFRB | CTPS | CTPS: CTP synthase 1 | 6.73 | Evidence | |||||
PDGFRB | SRPK2 | SRPK2: Serine/threonine-protein kinase SRPK2 | 6.67 | Evidence | |||||
PDGFRB | KIAA0664 | KIAA0664: Putative eukaryotic translation initiation factor 3 subunit | 6.63 | Evidence | |||||
PDGFRB | CTNNB1 | CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 | 6.63 | Evidence | |||||
PDGFRB | BTK | N/A | 6.59 | Evidence | |||||
PDGFRB | TNFSF13B | TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto | 6.40 | Evidence | |||||
PDGFRB | EDNRB | EDNRB, ETRB: Endothelin B receptor precursor | 6.40 | Evidence | |||||
PDGFRB | SNAP25 | N/A | 6.40 | Evidence | |||||
PDGFRB | PKN3 | PKN3, PKNBETA: Serine/threonine-protein kinase N3 | 6.11 | Evidence | |||||
PDGFRB | BTLA | BTLA: B- and T-lymphocyte attenuator precursor | 6.11 | Evidence | |||||
PDGFRB | PKN2 | PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 | 5.97 | Evidence | |||||
PDGFRB | CDK5 | CDK5: Cell division protein kinase 5 | 5.97 | Evidence | |||||
PDGFRB | MAPK12 | MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 | 5.97 | Evidence | |||||
PDGFRB | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 5.97 | Evidence | |||||
PDGFRB | RPS6KB1 | N/A | 5.97 | Evidence | |||||
PDGFRB | PLCD1 | DKFZp686K101: Putative uncharacterized protein DKFZp686K101 | 5.83 | Evidence | |||||
PDGFRB | TOM1L1 | TOM1L1, SRCASM: TOM1-like protein 1 | 5.76 | Evidence | |||||
PDGFRB | SCML2 | SCML2: Sex comb on midleg-like protein 2 | 5.76 | Evidence | |||||
PDGFRB | ETS2 | ETS2: Protein C-ets-2 | 5.76 | Evidence | |||||
PDGFRB | NACA | NACA, HSD48: Nascent polypeptide-associated complex subunit alpha | 5.70 | Evidence | |||||
PDGFRB | FXR1 | FXR1: Fragile X mental retardation syndrome-related protein 1 | 5.47 | Evidence | |||||
PDGFRB | CFL1 | CFL1, CFL: Cofilin-1 | 5.47 | Evidence | |||||
PDGFRB | DDR1 | DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE: Epithelial discoidin domain-con | 5.47 | Evidence | |||||
PDGFRB | VIL1 | VIL1, VIL: Villin-1 | 5.42 | Evidence | |||||
PDGFRB | FABP5 | FABP5: Fatty acid-binding protein, epidermal | 5.39 | Evidence | |||||
PDGFRB | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 5.34 | Evidence | |||||
PDGFRB | TSHR | N/A | 5.28 | Evidence | |||||
PDGFRB | H1FX | H1FX: Histone H1x | 5.15 | Evidence | |||||
PDGFRB | SPRED2 | SPRED2: Sprouty-related, EVH1 domain-containing protein 2 | 5.14 | Evidence | |||||
PDGFRB | EIF4G1 | EIF4G1, EIF4F, EIF4G, EIF4GI: Eukaryotic translation initiation factor 4 gamma 1 | 5.08 | Evidence | |||||
PDGFRB | CTDP1 | CTDP1, FCP1: RNA polymerase II subunit A C-terminal domain phosphatase | 5.08 | Evidence | |||||
PDGFRB | FXR2 | FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 | 4.86 | Evidence | |||||
PDGFRB | RASGRF2 | RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment) | 4.80 | Evidence | |||||
PDGFRB | CENTB5 | KIAA1716, CENTB5: Centaurin-beta 5 | 4.80 | Evidence | |||||
PDGFRB | SRA1 | APBB3, FE65L2: Amyloid beta A4 precursor protein-binding family B member 3 | 4.80 | Evidence | |||||
PDGFRB | ASB17 | ASB17: Ankyrin repeat and SOCS box protein 17 | 4.80 | Evidence | |||||
PDGFRB | PLEKHA4 | PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 | 4.80 | Evidence | |||||
PDGFRB | CAPN12 | CAPN12: Calpain-12 | 4.80 | Evidence | |||||
PDGFRB | FANK1 | FANK1, HSD13, UNQ6504/PRO21382: Fibronectin type 3 and ankyrin repeat domains pr | 4.80 | Evidence | |||||
PDGFRB | ASB6 | ASB6: Ankyrin repeat and SOCS box protein 6 | 4.80 | Evidence | |||||
PDGFRB | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 4.80 | Evidence | |||||
PDGFRB | MID2 | N/A | 4.80 | Evidence | |||||
PDGFRB | MUSK | MUSK: Muscle, skeletal receptor tyrosine protein kinase precursor | 4.56 | Evidence | |||||
PDGFRB | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 4.55 | Evidence | |||||
PDGFRB | LMAN1 | LMAN1, ERGIC53, F5F8D: Protein ERGIC-53 precursor | 4.55 | Evidence | |||||
PDGFRB | SYN1 | SYN1: Synapsin-1 | 4.49 | Evidence | |||||
PDGFRB | TRADD | TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein | 4.48 | Evidence | |||||
PDGFRB | RRAS | RRAS: Ras-related protein R-Ras precursor | 4.46 | Evidence | |||||
PDGFRB | TGFBR2 | TGFBR2: TGF-beta receptor type-2 precursor | 4.28 | Evidence | |||||
PDGFRB | PHC2 | PHC2, EDR2, PH2: Polyhomeotic-like protein 2 | 4.19 | Evidence | |||||
PDGFRB | PLK1 | PLK1, PLK: Serine/threonine-protein kinase PLK1 | 4.19 | Evidence | |||||
PDGFRB | IL2RG | IL2RG: Cytokine receptor common gamma chain precursor | 4.07 | Evidence | |||||
PDGFRB | GNA14 | GNA14: Guanine nucleotide-binding protein alpha-14 subunit | 4.03 | Evidence | |||||
PDGFRB | IL3RA | IL3RA, IL3R: Interleukin-3 receptor alpha chain precursor | 4.01 | Evidence | |||||
PDGFRB | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 4.01 | Evidence | |||||
PDGFRB | TNF | TNF, TNFA, TNFSF2: Tumor necrosis factor precursor | 3.79 | Evidence | |||||
PDGFRB | IL8RB | IL8RB, CXCR2: High affinity interleukin-8 receptor B | 3.79 | Evidence | |||||
PDGFRB | DAPK2 | DAPK2: Death-associated protein kinase 2 | 3.78 | Evidence | |||||
PDGFRB | CRIP2 | CRIP2, CRP2: Cysteine-rich protein 2 | 3.78 | Evidence | |||||
PDGFRB | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 3.62 | Evidence | |||||
PDGFRB | HLA-DOB | HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor | 3.62 | Evidence | |||||
PDGFRB | IFNGR2 | IFNGT1, IFNGR2: Interferon-gamma receptor beta chain precursor | 3.62 | Evidence | |||||
PDGFRB | PLK4 | PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 | 3.62 | Evidence | |||||
PDGFRB | DOK4 | DOK4: Docking protein 4 | 3.58 | Evidence | |||||
PDGFRB | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 3.51 | Evidence | |||||
PDGFRB | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 3.4 | Evidence | |||||
PDGFRB | CRK | N/A | 3.39 | Evidence | O | ||||
PDGFRB | PDE6G | DKFZp686N1686, PDE6G, hCG_38056: Putative uncharacterized protein DKFZp686N1686 | 3.3 | Evidence | |||||
PDGFRB | SLC9A3R2 | SLC9A3R2: SLC9A3R2 protein (Fragment) | 3.28 | Evidence | |||||
PDGFRB | SIVA | SIVA1, SIVA: Apoptosis regulatory protein Siva | 3.28 | Evidence | |||||
PDGFRB | BCR | N/A | 3.28 | Evidence | |||||
PDGFRB | SPAST | SPAST, KIAA1083, SPG4: Spastin | 3.28 | Evidence | |||||
PDGFRB | AXIN1 | 3.28 | Evidence | ||||||
PDGFRB | GPRASP2 | GPRASP2: G-protein coupled receptor-associated sorting protein 2 | 3.28 | Evidence | |||||
PDGFRB | STAP2 | Uncharacterized protein ENSP00000317912 | 3.28 | Evidence | |||||
PDGFRB | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 3.20 | Evidence | |||||
PDGFRB | OSTF1 | N/A | 3.20 | Evidence | |||||
PDGFRB | SNX15 | SNX15: Sorting nexin-15 | 3.15 | Evidence | |||||
PDGFRB | RICS | RICS: Rac GTPase activating protein | 3.15 | Evidence | |||||
PDGFRB | PRMT5 | PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 | 3.0 | Evidence | |||||
PDGFRB | SMC4L1 | SMC4, CAPC, SMC4L1: Structural maintenance of chromosomes protein 4 | 2.93 | Evidence | |||||
PDGFRB | DCP1B | DCP1B: mRNA-decapping enzyme 1B | 2.93 | Evidence | |||||
PDGFRB | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 2.93 | Evidence | |||||
PDGFRB | DCTN1 | DCTN1: Dynactin subunit 1 | 2.93 | Evidence | |||||
PDGFRB | ASB12 | ASB12: Ankyrin repeat and SOCS box protein 12 | 2.91 | Evidence | |||||
PDGFRB | RASA4 | RASA4, CAPRI, GAPL, KIAA0538: Ras GTPase-activating protein 4 | 2.87 | Evidence | |||||
PDGFRB | NCF2 | NCF2: Neutrophil cytosol factor 2 | 2.84 | Evidence | |||||
PDGFRB | PRKR | EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki | 2.77 | Evidence | O | ||||
PDGFRB | SHC1 | SHC1, RP11-307C12.1-001, hCG_1997126: SHC | 2.70 | Evidence | |||||
PDGFRB | CAMK2D | CAMK2D, CAMKD: Calcium/calmodulin-dependent protein kinase type II delta chain | 2.70 | Evidence | |||||
PDGFRB | SH2D4A | SH2D4A, SH2A: SH2 domain-containing protein 4A | 2.70 | Evidence | |||||
PDGFRB | MAPK7 | mitogen-activated protein kinase 7 isoform 1 | 2.44 | Evidence | |||||
PDGFRB | ANXA6 | ANXA6, ANX6: Annexin A6 | 2.40 | Evidence | |||||
PDGFRB | GRIN2B | GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor | 2.39 | Evidence | |||||
PDGFRB | TBK1 | TBK1, NAK: Serine/threonine-protein kinase TBK1 | 2.3 | Evidence | |||||
PDGFRB | SHC4 | SHC-transforming protein 4 | 2.23 | Evidence | |||||
PDGFRB | LOC392481 | N/A | 2.23 | Evidence | |||||
PDGFRB | ESPL1 | N/A | 2.18 | Evidence | |||||
PDGFRB | CASP8 | N/A | 2.18 | Evidence | |||||
PDGFRB | USP10 | USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 | 2.18 | Evidence | |||||
PDGFRB | TRAF2 | TRAF2, TRAP3: TNF receptor-associated factor 2 | 2.18 | Evidence | |||||
PDGFRB | STIP1 | STIP1: Stress-induced-phosphoprotein 1 | 2.18 | Evidence | |||||
PDGFRB | CHUK | N/A | 2.18 | Evidence | |||||
PDGFRB | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 2.15 | Evidence | |||||
PDGFRB | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 2.11 | Evidence | |||||
PDGFRB | LTK | LTK, TYK1: Leukocyte tyrosine kinase receptor precursor | 1.96 | Evidence | |||||
PDGFRB | HNRPK | N/A | 1.96 | Evidence | |||||
PDGFRB | AGTPBP1 | AGTPBP1, RP11-30C23.1-005, hCG_1743691: AGTPBP1 protein | 1.96 | Evidence | |||||
PDGFRB | EEF1G | EEF1G, EF1G, PRO1608: Elongation factor 1-gamma | 1.96 | Evidence | |||||
PDGFRB | PSMD11 | PSMD11: 26S proteasome non-ATPase regulatory subunit 11 | 1.96 | Evidence | |||||
PDGFRB | CCT2 | CCT2, 99D8.1, CCTB: T-complex protein 1 subunit beta | 1.96 | Evidence | |||||
PDGFRB | RARS | RARS: Arginyl-tRNA synthetase, cytoplasmic | 1.96 | Evidence | |||||
PDGFRB | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 1.96 | Evidence | |||||
PDGFRB | ABCF1 | N/A | 1.94 | Evidence | |||||
PDGFRB | BRCA2 | BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein | 1.94 | Evidence | |||||
PDGFRB | LIMS1 | N/A | 1.94 | Evidence | |||||
PDGFRB | ALOX5 | ALOX5, LOG5: Arachidonate 5-lipoxygenase | 1.94 | Evidence | |||||
PDGFRB | VCPIP1 | VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 | 1.94 | Evidence | |||||
PDGFRB | VAV2 | VAV2, RP11-153P4.1-003: Vav 2 oncogene | 1.94 | Evidence | |||||
PDGFRB | APBA3 | APBA3, MINT3, X11L2: Amyloid beta A4 precursor protein-binding family A member 3 | 1.81 | Evidence | |||||
PDGFRB | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 1.78 | Evidence | |||||
PDGFRB | RAD51 | RAD51, RAD51A, RECA: DNA repair protein RAD51 homolog 1 | 1.78 | Evidence | |||||
PDGFRB | RAC1 | N/A | 1.78 | Evidence | |||||
PDGFRB | COPA | COPA: Coatomer subunit alpha | 1.74 | Evidence | O | ||||
PDGFRB | PTPN11 | N/A | 1.74 | Evidence | |||||
PDGFRB | DPF2 | DPF2, REQ, UBID4: Zinc finger protein ubi-d4 | 1.74 | Evidence | |||||
PDGFRB | EVL | N/A | 1.74 | Evidence | |||||
PDGFRB | MTHFD1 | MTHFD1, MTHFC, MTHFD: C-1-tetrahydrofolate synthase, cytoplasmic | 1.74 | Evidence | |||||
PDGFRB | APC | N/A | 1.74 | Evidence | |||||
PDGFRB | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 1.74 | Evidence | |||||
PDGFRB | CTNND2 | CTNND2, NPRAP: Catenin delta-2 | 1.74 | Evidence | |||||
PDGFRB | DNM1 | N/A | 1.74 | Evidence | |||||
PDGFRB | CASP3 | CASP3, CPP32: Caspase-3 precursor | 1.74 | Evidence | |||||
PDGFRB | USP47 | USP47: Ubiquitin carboxyl-terminal hydrolase 47 | 1.74 | Evidence | |||||
PDGFRB | PPP1R12A | PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A | 1.74 | Evidence | |||||
PDGFRB | YWHAG | YWHAG: 14-3-3 protein gamma | 1.71 | Evidence | |||||
PDGFRB | PPIA | PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A | 1.55 | Evidence | |||||
PDGFRB | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 1.55 | Evidence | |||||
PDGFRB | SOS2 | SOS2: Son of sevenless homolog 2 | 1.44 | Evidence | |||||
PDGFRB | YWHAQ | YWHAQ: 14-3-3 protein theta | 1.32 | Evidence | |||||
PDGFRB | MCM3 | MCM3: DNA replication licensing factor MCM3 | 1.29 | Evidence | |||||
PDGFRB | EIF5B | EIF5B, IF2, KIAA0741: Eukaryotic translation initiation factor 5B | 1.18 | Evidence | |||||
PDGFRB | YWHAZ | YWHAZ: 14-3-3 protein zeta/delta | 1.18 | Evidence | |||||
PDGFRB | NRAS | NRAS, HRAS1: GTPase NRas precursor | 1.18 | Evidence | |||||
PDGFRB | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 1.18 | Evidence | |||||
PDGFRB | ANKK1 | ANKK1, PKK2, SGK288: Ankyrin repeat and protein kinase domain-containing protein | 1.18 | Evidence | |||||
PDGFRB | PHB2 | PHB2, BAP, REA: Prohibitin-2 | 1.17 | Evidence | |||||
PDGFRB | MAP2K6 | MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki | 1.17 | Evidence | |||||
PDGFRB | VCP | VCP: Transitional endoplasmic reticulum ATPase | 1.17 | Evidence | |||||
PDGFRB | CLTCL1 | CLTCL1, CLH22, CLTCL, CLTD: Clathrin heavy chain 2 | 1.07 | Evidence | |||||
PDGFRB | PTPRS | N/A | 1.07 | Evidence |